Active Ingredient (In Each Tablet)
Phenylephrine HCL 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by Yyba Corp for the product Nasal Decongestant Pe (NDC 73581-204). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Phenylephrine HCL 10 mg
Nasal decongestant
Do not use if you are taking a prescription monoamine oxidase inhibitor (MA0l)(certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MA0l drug. If you do not know if your prescription drug contains an MA0l, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
When using this product do not exceed recommended dosage.
Stop use and ask a doctor if
If pregnant or breast-feeding, as a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away [1-800-222-1222]
take 1 tablet 4 hours. Do not take more than 6 tablets in 24 hours
croscarmellose sodium, dextrose monohydrate, dicalcium phosphate dihydrate, FD&C red #40. lecithin, magnesium stearate, maltrodextrin, microcrystalline cellulose, silicon dioxide, sodium carboxymethylcellulose, sodium citrate dihydrate, titanium dioxide
call toll-free 1-866-933-6337
* Please review the disclaimer below.